Welcome to our dedicated page for Oracle SEC filings (Ticker: ORCL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Oracle Corporation’s (ORCL) U.S. Securities and Exchange Commission filings, giving investors a primary source of information on the company’s governance, capital structure, and material events. Oracle’s common stock, par value $0.01 per share, is registered under Section 12(b) of the Exchange Act and listed on the New York Stock Exchange under the symbol ORCL, as disclosed in multiple Forms 8‑K.
Among Oracle’s key filings are current reports on Form 8‑K, which document events such as quarterly financial results, cash dividend declarations, leadership and board changes, and significant financing transactions. Recent 8‑K filings describe press releases announcing fiscal quarter results, the declaration of cash dividends on Oracle’s common stock, the promotion of executives to Chief Executive Officer roles and Principal Financial Officer, the appointment and retirement of directors, and the issuance of senior notes under an existing shelf registration statement.
Oracle’s definitive proxy statement on Schedule 14A (DEF 14A) outlines matters for its annual meeting of stockholders, including the election of directors, an advisory vote on executive compensation, and ratification of its independent registered public accounting firm. The proxy statement also discusses board structure, committees, corporate governance guidelines, stock ownership policies, and executive compensation programs.
Investors may also find Form 25 filings relevant for specific Oracle debt securities. Oracle has filed a Form 25‑NSE relating to the removal from listing of its 3.125% Notes due 2025 from the New York Stock Exchange. This filing concerns a class of notes and is separate from the listing of Oracle’s common stock.
On Stock Titan, Oracle’s SEC filings are organized chronologically and can be paired with AI‑powered summaries that explain the purpose and implications of each document. This helps readers quickly understand items such as 8‑K event descriptions, proxy proposals, and capital markets transactions, while still allowing direct access to the full text of Oracle’s submissions to the SEC.
Oracle Corp (ORCL) insider filing: the Chief Executive Officer reported an open-market sale (Transaction Code S) of 40,000 shares on 10/21/2025 at a weighted average price of $276.6377. The filing notes the sale was executed in multiple trades priced between $276.60 and $276.91.
Following this transaction, the reporting person beneficially owned 154,030 shares on a direct basis.
Oracle (ORCL) received a Form 144 notice for a proposed sale of 5,000 shares of common stock. The notice lists an aggregate market value of $1,403,122.87, with sales expected on 10/23/2025 through Fidelity Brokerage Services LLC on the NYSE.
The shares were acquired via restricted stock vesting in four tranches: 1,286 (12/05/2023), 1,620 (08/03/2024), 1,240 (08/04/2024), and 854 (09/15/2024), totaling 5,000. The filing also notes a separate sale by Maria Smith of 5,000 shares on 10/21/2025 for $1,400,000.00.
Oracle (ORCL) received a Form 144 notice for a proposed insider sale of 49,365 shares of common stock. The filing lists an aggregate market value of $13,387,294.35, with an approximate sale date of October 28, 2025.
The shares are indicated for sale on the NYSE through APEX Clearing. The seller’s holdings include awards acquired via RSUs from Oracle on multiple dates, such as 01/07/2013, 05/31/2018, 05/31/2020, 05/31/2021, 05/31/2022, 05/31/2024, and 05/31/2025.
Oracle (ORCL) filed a Form 144 notice for a proposed sale of 40,000 common shares. The filing lists an aggregate market value of $11,065,506.10, with an approximate sale date of 10/21/2025 on the NYSE through Fidelity Brokerage Services LLC.
The shares to be sold were acquired via restricted stock vesting: 37,270 shares on 09/15/2025 and 2,730 shares on 09/19/2025. Shares outstanding are stated as 2,841,714,000. In the past three months, the person for whose account the sale is proposed sold 21,241 shares on 09/12/2025 for gross proceeds of $6,310,864.10.
Oracle (ORCL): A holder filed a Form 144 notice to sell 5,000 shares of Oracle common stock, with an aggregate market value of $1,400,000. The planned sale is indicated for 10/21/2025 through Fidelity Brokerage Services LLC on the NYSE.
The shares were acquired via restricted stock vesting from the issuer in two tranches: 3,384 shares on 09/15/2024 and 1,616 shares on 08/03/2025. A Form 144 is a notice of a proposed sale under SEC Rule 144 and does not register new securities.
Oracle (ORCL) reported an insider transaction on a Form 4. On 10/10/2025, an officer (EVP, Chief Legal Officer) sold 19,758 shares of common stock at $300 per share, coded “S.” Following the sale, the officer beneficially owned 18,429 shares, held directly. The filing notes the sale was made under a Rule 10b5-1 trading plan adopted on July 10, 2025.
This Form 144 shows a proposed sale of 19,758 common shares of Oracle Corporation (ORCL) through Fidelity Brokerage Services LLC on the
Oracle Corporation filed an amended report to update compensation details for recently promoted senior executives. The amendment follows earlier disclosures about the appointments of Clayton Magouyrk and Michael Sicilia as Chief Executive Officers and Board members, and Douglas Kehring as Executive Vice President and Principal Financial Officer, effective September 22, 2025.
On September 30, 2025, the Compensation Committee set the annual base salary for each of Magouyrk, Sicilia and Kehring at $950,000, effective as of the appointment date. For the fiscal year ending May 31, 2026, Magouyrk and Sicilia each received an annual target cash bonus opportunity of $5,000,000 under the Oracle Executive Bonus Plan, while Kehring received a target cash bonus of $950,000 under Oracle’s discretionary corporate bonus plan. Kehring is also eligible for ordinary course equity-based awards during FY26 under Oracle’s 2020 Equity Incentive Plan.
Douglas A. Kehring, Executive Vice President and Principal Financial Officer of Oracle Corp (ORCL), filed an initial Form 3 reporting his beneficial ownership. He directly owns 68,592 shares of Oracle common stock and indirectly holds 2,157.514 units through the company 401(k) plan. He also holds unvested restricted stock units totaling 212,... (213,101) RSUs from three prior grants that convert one-for-one to common shares upon settlement and vest in annual installments.
Mark Hura filed an initial Form 3 reporting his beneficial ownership in Oracle Corporation (ORCL) following his appointment as President, Global Field Operations. The filing reports 254,077 shares of Oracle common stock held directly and 162,959 unvested restricted stock units (RSUs) that each convert to one share at settlement. The RSUs come from three prior grants: 190,868 RSUs granted 09/20/2022 (vesting in four equal annual installments), 114,126 RSUs granted 09/15/2023 (four annual installments), and 77,571 RSUs granted 09/19/2024 (four annual installments).
The statement was signed by an attorney-in-fact on behalf of Mr. Hura on 10/01/2025 and reflects holdings as of the 09/22/2025 event date. All reported RSUs are unvested and scheduled to vest in equal annual tranches starting on each grant's first anniversary, indicating future potential share settlement rather than current voting shares.
FAQ
What is the current stock price of Oracle (ORCL)?
What is the market cap of Oracle (ORCL)?
